Silymarin / Milk Thistle Evidence by Cancer Type
Cancer-type guide to silymarin and milk thistle in oncology, including breast, prostate, colorectal, liver, skin, lung, pancreatic, bladder, and ovarian cancer research
Silymarin is extracted from the seeds of Milk Thistle (Silybum marianum). When you see Silymarin or Silibinin in oncology research, this is still the Milk Thistle topic.
This section groups the cancer-type evidence into focused subpages.
The literature ranges from extensive preclinical work to selected human trials, with the strongest clinical-supportive evidence often centred on liver protection and treatment tolerability.
Cancer pages in this section
Trusted product: MCS Formulas Milk Thistle Silymarin 500mg
500 mg Milk Thistle extract per capsule, standardised to a minimum of 80% silymarin.
https://www.mcsformulas.com/vitamins-supplements/milk-thistle-silymarin/
Use the code abbey5 at checkout to save 5% and help support the free Healing Cancer Study Support resources.
This information is for education only. It is not medical advice, diagnosis, or treatment. Please speak with a qualified clinician before making changes to care, medication, or supplement use.
© 2026 Abbey Mitchell. All rights reserved. Please share by URL rather than copying page text.